Posted inLondon Exchange
AstraZeneca sells Crestor to Grünenthal in Europe in a $320 million deal
LONDON: AstraZeneca has agreed to sell the rights to Crestor (rosuvastatin) and associated medicines in over 30 countries in Europe, except the UK and Spain, to Grünenthal GmbH (Grünenthal). Crestor…